Evotec to Present at the 19th Annual Piper Jaffray Health Care Conference in New York

HAMBURG, Germany and OXFORD, England, November 26 /PRNewswire-FirstCall/-- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that Jorn Aldag,President & CEO, and Dr John Kemp, Chief Research & Development Officer, willpresent at the 19th Annual Piper Jaffray Health Care Conference in New York.

A live webcast of the presentation will be accessible through the Evotecwebsite at http://www.evotec.com - Investors. A replay will be available athttp://www.evotec.com - Investors - Webcasts.Date: Wednesday, 28 November 2007 Time: 12.00 pm EST (06.00 pm CET/05.00 pm GMT) Location: The Pierre Hotel, New York City

SOURCE Evotec AG

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...